Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Black Diamond Therapeutics, Inc.
IPO Date: January 31, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $167.74M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.37 | 3.70%
Avg Daily Range (30 D): $0.08 | 3.09%
Avg Daily Range (90 D): $0.08 | 3.89%
Institutional Daily Volume
Avg Daily Volume: .65M
Avg Daily Volume (30 D): .99M
Avg Daily Volume (90 D): 2.43M
Trade Size
Avg Trade Size (Sh.): 132
Avg Trade Size (Sh.) (30 D): 169
Avg Trade Size (Sh.) (90 D): 222
Institutional Trades
Total Inst.Trades: 370
Avg Inst. Trade: $1.83M
Avg Inst. Trade (30 D): $3.32M
Avg Inst. Trade (90 D): $2.62M
Avg Inst. Trade Volume: .16M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.28M
Avg Closing Trade (30 D): $7.95M
Avg Closing Trade (90 D): $4.23M
Avg Closing Volume: 172.61K
   
News
Mar 19, 2025 @ 11:00 AM
Servier and Black Diamond Therapeutics AnnounceÂÂ...
Source: N/A
Jan 29, 2025 @ 6:00 PM
BRAF Inhibitors Market to Register Incremental Gro...
Source: Delveinsight
Nov 5, 2024 @ 1:00 PM
Black Diamond Therapeutics Reports Third Quarter 2...
Source: N/A
Oct 7, 2024 @ 8:01 PM
Black Diamond Therapeutics Announces Restructuring...
Source: N/A
Sep 22, 2024 @ 2:00 PM
Black Diamond Therapeutics to Host Webcast Present...
Source: N/A
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $.08 $1 $-.28
Diluted EPS $.06 $.98 $-.28
Revenue $ 70M $ 70M $ M
Gross Profit $ $ $
Net Income / Loss $ 5.09M $ 56.54M $ -15.99M
Operating Income / Loss $ -4.01M $ 54.53M $ -18.28M
Cost of Revenue $ $ $
Net Cash Flow $ 73M $ 61.99M $ 13.01M
PE Ratio 53.17